Background: 3,4-methylenedioxymethamphetamine (MDMA), known recreationally as "Molly" or "Ecstasy", is a triple monoamine reuptake inhibitor. MDMA specifically acts as a weak 5-HT1 and 5-HT2 receptor agonist, targeting 5-HT2A, 5-HT2B, and 5-HT2C receptors. Its potential use for therapeutic purposes with these pharmacological profiles remains a controversial subject. Studies have shown the...
The Spectrum of Dissociative Disorders are based on criteria that define the dissociative experience of depersonalization along the spatial dimension with patients having dissociative episodes typically describe the experience of being spatially removed from the first person experience. We present the unique case of a patient with Other Specified Dissociative Disorder who exhibits...